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ABSTRACT
Introduction Approximately 17% of adults with 
intellectual disabilities (ID) living in the community 
display behaviours that challenge. Intensive support 
teams (ISTs) have been recommended to provide high- 
quality responsive care aimed at avoiding unnecessary 
admissions and reducing lengthy inpatient stays in 
England. We have identified two models of ISTs (model 1: 
enhanced provision and model 2: independent provision). 
This study aims to investigate the clinical and cost- 
effectiveness of the two models of ISTs.
Methods and analysis A cohort of 226 adults with ID 
displaying behaviour that challenges who receive support 
from ISTs from each model will be recruited and assessed 
at baseline and 9 months later to compare the clinical 
and cost- effectiveness between models. The primary 
outcome is reduction in challenging behaviour measured 
by the Aberrant Behaviour Checklist- Community (ABC- C). 
The mean difference in change in ABC score between the 
two IST models will be estimated from a multilevel linear 
regression model. Secondary outcomes include mental 
health status, clinical risk, quality of life, health- related 
quality of life, level of functioning and service use. We 
will undertake a cost- effectiveness analysis taking both 
a health and social care and wider societal perspective. 
Semistructured interviews will be conducted with multiple 
stakeholders (ie, service users, paid/family carers, IST 
managers/staff) to investigate the experience of IST care 
as well as an online survey of referrers to capture their 
contact with the teams.
Ethics and dissemination The study was approved by 
the London–Bromley Research Ethics Committee (REC 
reference: 18/LO/0890). Informed consent will be obtained 
from the person with ID, or a family/nominated consultee 
for those lacking capacity and from his/her caregivers. 
The findings of the study will be disseminated to academic 
audiences, professionals, experts by experience and 
arm’s- length bodies and policymakers via publications, 
seminars and digital platforms.
Trial registration number  ClinicalTrials. gov Registry 
(NCT03586375).
INTRODUCTION
People with intellectual (also called learning) 
disabilities (ID), characterised by cognitive 
delay and difficulties in adaptive functioning, 
constitute approximately 1% of the popula-
tion.1 Seventeen per cent of adults with ID, 
living in the community, present with serious 
challenging behaviour including aggression, 
self- injury or other socially inappropriate 
behaviours.2 As many as 100, 000 children 
and adults are estimated to be at risk of 
admission to inpatient care due to the pres-
ence of such behaviours if they are not effec-
tively supported in the community.3 There 
are ongoing concerns that these individuals 
are subject to increased rates of hospitalisa-
tion, unnecessary long- term use of psycho-
tropic medication, poorer health, abuse and 
exclusion.4
Intensive support teams (ISTs) are specialist 
teams which have been advocated for many 
years as the best services to help people with 
ID and challenging behaviour remain within 
their local communities. The teams may 
Strengths and limitations of this study
 ► This study will be the first systematic national eval-
uation of intensive support team (IST) models for 
adults with intellectual disability who display chal-
lenging behaviour.
 ► Accessing the experience of stakeholders (eg, IST 
managers, staff members, family and paid carers, 
and service users) will enable an in- depth under-
standing of how ISTs function and how they respond 
to people with complex needs.
 ► This is not a randomised controlled trial so may 
be subject to biases associated with observational 
research.
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be staffed by one or more professions (eg, psychology, 
nursing, psychiatry). They deliver interventions such as 
positive behaviour support, support adults with ID who 
are in a mental or behavioural crisis, and provide inreach 
when a person is admitted to a psychiatric inpatient 
facility.5 6 ISTs are recommended to provide high- quality 
proactive and responsive care aimed at avoiding unneces-
sary admissions or reducing inpatient length of stay and 
maintaining people in their local community.6 7 However, 
there is little evidence to recommend a preferred IST 
model or way of implementing these aims, and there has 
not been a comprehensive attempt to describe the clinical 
and cost- effectiveness of ISTs. Such information would 
be needed by health funders in order to fund services fit 
for purpose. The National Institute of Health and Care 
Excellence Guideline (NG11)8 reports that: ‘It is widely 
recognised that locally accessible care settings could be 
beneficial and could reduce costs but there is no strong 
empirical evidence to support this’.
Previous studies describe either demonstration proj-
ects following the closure of institutions9 10 or region- 
wide implementation of standalone services.11 Three 
small controlled trials have examined, respectively: (1) a 
standalone specialist- support service delivering standard 
treatment in addition to behaviour therapy in one area 
in England12; (2) a standalone team delivering asser-
tive outreach for adults with ID who display challenging 
behaviour in inner London13 and (3) an active case 
management model.14 Comparator treatment was usual 
care in all three studies. The remit of the ISTs differed 
between studies, with one providing support to people 
who display challenging behaviour while the other two 
provided a replication of the intensive support manage-
ment from adult mental healthcare. These small studies 
presented equivocal findings in terms of reduction in 
challenging behaviour, improved level of functioning and 
quality of life dependent on the model.
A study15 showed that positive behavioural outcomes 
may be achieved by an embedded IST model in which 
a core team of community ID service staff trained in 
managing challenging behaviour meet together regu-
larly to discuss referrals with specialist supervision and 
peer support by the lead clinician. Literature from other 
population groups (eg, dementia care)16 and adult 
mental health17 suggests that home treatment teams may 
be effective in managing crises and reducing admissions. 
Wheeler et al18 showed that stakeholders in adult mental 
healthcare have a number of expectations from crisis 
resolution teams and this is likely to be the case for ISTs 
in the field of ID. So far, there has been limited reporting 
on stakeholder experiences of ISTs,15 18 so little is known 
whether service users and paid and family carers find the 
involvement of IST staff and frequency of contact helpful 
and acceptable.
As part of the Transforming Care programme,19 the 
National Health Service (NHS) England has prioritised 
ISTs as a central pillar in the arsenal of support for individ-
uals who display challenging behaviour, and has invested 
in a variety of formats of such teams in areas with high 
admission rates. The current study is the second phase of 
a wider project that set out to systematically examine the 
implementation of ISTs in England.
The first phase identified two IST service models20: 
enhanced provision (model 1) and independent provi-
sion (model 2) following an England- wide survey of ISTs 
(n=73).20 The components of each model as reported by 
professionals in the survey are shown below (table 1).
There is limited evidence for the comparative clinical 
and cost- effectiveness of either enhanced or indepen-
dent provision15 and of long- term clinical gains. Further-
more, satisfaction of stakeholders with the ISTs has hardly 
featured in the literature and that deserves better under-
standing if the ISTs are fit for purpose and responsive to 
patient need.
OBJECTIVES
The overall aim of phase 2 of the study is to investigate 
patient outcomes (eg, challenging behaviour, risk, adap-
tive behaviour, service use, quality of life) and service- 
level outcomes (eg, engagement with the IST, satisfaction 
with referral process, number of referrals, experience of 
care provided).
Specific objectives
 ► To generate evidence regarding which IST model best 
supports improved outcomes for adults who display 
challenging behaviour.
 ► To estimate the costs of the two IST models and 
examine cost- effectiveness.
 ► To explore views and experiences of ISTs among 
relevant stakeholders (service users, paid and family 
carers, and service providers).
 ► To investigate how ISTs impact the lives of adults with 
IDs who display challenging behaviour in their case-
load, their families and the local services.
Findings will generate evidence to inform and support 
decision- making on commissioning of ISTs for adults with 
ID who display challenging behaviour.





Integrated within the broader 
Community Intellectual 
Disability Services
Separate from Community 
Intellectual Disability 
Services
Long- term support (more than 
6 months)
Short- term support (3–12 
months)
Accept self- referrals Referral via professionals
Large caseload (20+) Small caseload (up to 15)
Less likely to use outcome 
measures
Use of outcome measures
IST, intensive support team.
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METHODS AND ANALYSIS
The research team will compare the two models, 
enhanced provision and independent provision, respec-
tively, of ISTs already identified in phase 1 of the study.20 
The research assistant or clinical study officers will collect 
study participant- level outcomes at two assessment points 
(baseline and 9 months) and service- level outcomes over 
the same time period. The research assistant will also 
collect qualitative data to understand the experiences 
and views of key stakeholders, and stakeholder experi-
ences of the different models.
Setting and participants
Eight enhanced service provision ISTs and eight inde-
pendent service provision ISTs (table 1) will be selected 
at random from ISTs surveyed in phase 1 of the study.20 
Service users, either already under the care of the 16 ISTs 
or newly referred, and their caregivers will be identified 
by IST staff either at first clinical assessment or from the 
IST services caseloads and asked if they are interested 
in taking part in the study. Following an expression of 
interest, the researchers will contact them to provide 
information about the study and to obtain written or 
audio- recorded informed consent from those agreeing to 
undergo further research assessments.
Inclusion criteria
1. Service: IST adheres to one of the identified models 
(table 1); has been operational for at least 12 months; 
there is commitment to fund it for the study duration 
and it can achieve the sample size estimates.
2. Service users: receive support from IST service; mild to 
profound ID based on clinical diagnosis; aged 18 years 
and over.
Exclusion criteria
1. Service: has been operational for less than 12 months 
at selection or there are plans to dissolve it.
2. Service users: primary clinical diagnosis of personality 
disorder or substance misuse; decision by clinical team 
a referral to the study would be inappropriate (eg, due 
to ongoing legal challenges to the service or the per-
son being acutely unwell).
Consent
Consent will be sought from service users and their 
respective carers (ie, paid and family) and/or nominated 
consultees where the participant with ID lacks capacity 
in accordance with the Mental Capacity Act 2005.8 For 
those service users with decision- making capacity, the 
researcher will speak to the potential participant by 
phone or in person and will give or send the service user 
participant information sheet (in Easy Read format) to 
inform them of the study. If the service user agrees to take 
part in the study, the individual will complete a written 
consent form or consent will be taken by telephone and 
audio- recorded for purposes of verifying consent. The 
researcher will then repeat the above process (using the 
carer participant information sheet) with the service 
users’ paid or family carer to seek their consent to take 
part and complete the rest of the study measures. For 
those service users lacking decision- making capacity, 
the researcher will approach the personal or nominated 
consultee for that person (using the consultee informa-
tion sheet) and seek written or audio- recorded advice 
about including the service user in the study.
Outcome measures
Study participant-level outcomes
Each participant will be recruited at any point of IST 
care and will be assessed at baseline and at 9 months 
which reflects the time period an IST may be expected 
to be involved in working with a participant. This length 
of follow- up was chosen because our research and clin-
ical experience indicates that, while there is a range of 
duration for IST involvement, assessment and delivery of 
behaviour support plans usually require about 3 months 
to complete and adults with ID and challenging behaviour 
often remain in the care of the IST for approximately 12 
months.
The primary outcome is challenging behaviour 
measured by the Aberrant Behaviour Checklist- 
Community (ABC- C)21 which has been widely used in the 
target population and is completed by the caregiver (eg, 
family, paid care home staff, IST staff).
A range of secondary endpoints examine the following: 
the carer- reported Psychopathology Assessment for 
Adults with Developmental Disabilities checklist 22 is a 
mental health screening tool which provides sufficient 
information on potential mental health comorbidity 
that is often underascertained in adults with ID. The 
Threshold Assessment Grid23 measures clinical risk in 
adults with ID. The Quality of Life (QoL)24 will be used 
with the individual with ID and/or the caregiver, if partic-
ipants lack capacity, to measure the individual’s quality 
of life. The Adaptive Behaviour Scale- Short Form assesses 
level of functioning.25 The Client Service Receipt Inven-
tory (CSRI)26 (adapted for the study, 6- month retrospec-
tive service use at each assessment point) is a widely used 
service- use questionnaire and has been validated for use 
in mental health and ID services research.
Health- related quality of life will be measured by the 
EQ- 5D- 5L.27 The EQ- 5D is used to generate quality- 
adjusted life years (QALYs). The self- report version will 
be used with the individual with ID where possible, and 
the proxy version will be used with the caregiver in the 
cases of participants lacking capacity.
The researchers will collect sociodemographic informa-
tion, as well as number of hospital admissions and mainte-
nance of accommodation at follow- up.
The study participant flow chart is shown in figure 1.
Service-level outcomes
The researchers will collect data from all participating 
ISTs including the number of people referred; propor-
tion who engage with IST; time to first assessment and 
delivery of management plan; other IST scope (eg, days 
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of training given) and other engagement with local 
services (eg, joint assessments with crisis teams) that will 
provide additional information about the ISTs’ caseload 
size. We will map our service data onto the reports from 
the Mental Health and Learning Disabilities Data Set over 
the study period which provides information on hospital 
admissions and compares with admissions by IST model. 
This will provide a proxy measure of IST model impact 
on admissions.
Referrer’s questionnaire
Practitioners from community ID services who frequently 
refer to ISTs across all sites will be invited to complete a 
brief questionnaire designed to capture satisfaction with 
referral processes, reasons for referrals and number of 
referrals to IST. The questionnaire will be administered 
either online, via email or post, or a combination of these.
Qualitative substudy: stakeholder’s views of ISTs
An embedded qualitative substudy will allow to inves-
tigate how IST care is experienced by service users and 
family carers, and to obtain a multiperspective view of 
IST functioning within local service contexts, based on 
user, carer and practitioner views. The researchers will 
conduct semistructured interviews with (1) IST managers 
and staff, (2) service users, and (3) family and paid carers. 
Up to eight service users per IST model, including those 
who may need support to communicate (provided by 
family or paid carers); and up to eight carers (a mixture 
of family and paid) per IST model will be included. The 
researchers will also attempt to interview a small number 
of family carers who have recently declined IST contact. 
Purposive sampling will be employed, in order to include 
a range of ages, work experience, professional back-
grounds, and carer roles and relationships in our sample. 
In order to gain a broad perspective on IST implementa-
tion in England, the researchers will aim to conduct inter-
views with all managers of the IST services taking part in 
the phase 2. Interviews with IST managers and staff will be 
conducted in the early stages of the research study; inter-
views with service users and family and paid carers will be 
conducted near the time of discharge from IST services 
or around the 9- month follow- up, whichever is sooner.
The interview will take place at a location convenient 
(ie, home, clinic or remotely with the aid of technology) 
for the participant and will be audio- recorded. Across all 
stakeholder groups, interview schedules will be designed 
to explore views and experiences of the role and func-
tioning of ISTs, and how they interface with other health 
and social care provision within their local context. The 
semistructured interview schedule will address the oper-
ational functioning, benefits and limitations of ISTs, 
and explore the factors that might affect these following 
consultation with the patient and public involvement 
(PPI) representatives. In order to link stakeholder 
perspectives to specific service contexts, we aim to carry 
out data collection within seven IST ‘case study’ sites. 
These sites will be selected from the larger pool of the 16 
services, with an aim to include services that vary in terms 
of team size, caseload size and styles of working based on 
the reflections and other relevant information available 
to the research team. Four services will be selected as case 
studies of ‘independent’ ISTs and three services as case 
studies of ‘enhanced model’ ISTs. The use of case study 
sites is appropriate where the research focus is to assess 
‘mega systems’ of great complexity.28
Study termination
The end of the study will be the date of the 9- month 
follow- up assessment with the study participant. For 
those who take part in interviews, these will be arranged 
to take place shortly after the questionnaire completion. 
Further, if the study failed to recruit adequately, it would 
be discussed with the study Steering Committee and the 
funders as to whether it should stop or be extended.
Sample size
Based on two IST models, it was estimated that a sample 
of 96 participants per model (192 in total) would be 
required to detect a difference of 0.45 SDs in primary 
outcome score between the two models at the 5% signif-
icance level with 80% power and assuming an intraclass 
correlation of 0.02.12 29 After factoring in 15% loss to 
follow- up, the estimated sample size required increased 
to 113 participants per model (226 participants in total).
Statistical analysis plan
As per the predetermined statistical analysis plan, the 
baseline characteristics of participants will be summarised 
separately for the two IST models. Categorical variables 
will be reported as counts and percentages, while contin-
uous variables will be summarised as means and SDs or 
Figure 1 Study participant flow chart.
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medians and IQRs as appropriate depending on the 
distribution of the data.
The primary outcome is challenging behaviour 
measured by total score on the ABC. Change in ABC total 
score from baseline to 9- month follow- up will be calcu-
lated for each participant. The mean difference in ABC 
score between the two IST models will be estimated from 
a multilevel linear regression model with change in ABC 
score as the outcome, a fixed effect of model as the main 
exposure, and a random effect of IST to account for clus-
tering within services.
Age, gender, living arrangements, level of ID, level of 
risk, presence of autism and clinical comorbidities have 
been identified as potential confounders and will be spec-
ified as covariates in adjusted multilevel linear regression 
models similar to the main unadjusted model described 
above. The estimated difference in change in ABC total 
score from both unadjusted and adjusted models will be 
reported with accompanying 95% CI and p value.
The secondary outcomes detailed above will be anal-
ysed using statistical models analogous to those for the 
primary outcome. Binary outcomes will be analysed 
using multilevel logistic regression models. Non- normally 
distributed continuous outcomes will be analysed using 
the bootstrap method and bias corrected 95% CI will 
be reported. P values will not be reported for secondary 
outcomes.
Economic evaluation plan
As per the predetermined health economic analysis plan, 
we shall derive and report the costs of each IST service 
model over 9 months. To calculate the cost of each IST 
service model, we will use information on the description, 
time inputs of staff and related caseloads of professionals 
in the IST.
The cost- effectiveness analyses will be conducted from 
a health and social care perspective and a wider societal 
perspective. Data on health and social care services and 
support provided by statutory services external to the 
ISTs will be obtained from the CSRI covering a retro-
spective period of 6 months. To service use and support 
data, we shall attach unit costs taken from a wide range 
of sources.30 31 Costs of unpaid care will be estimated 
from information on volume and type of support, the 
opportunity cost of lost work (wage rate) for carers in 
paid employment and replacement cost for those not in 
paid employment based on cost of a home care worker. 
We shall extrapolate the 6- month costs over the 9- month 
period and examine the link between costs and sociode-
mographic, clinical characteristics of individuals in the 
study.
The cost- effectiveness of one IST model over another 
will be compared by calculating incremental cost- 
effectiveness ratios, defined as difference in mean costs 
divided by difference in mean effects. Cost- effectiveness 
acceptability curves32 will be plotted for each cost–
outcome combination to show the likelihood of one IST 
model as cost- effective relative to another for a range 
of (implicit) values placed on incremental outcome 
improvements. Using the net benefit (NB) approach, 
monetary values of incremental effects and incremental 
costs are combined, and NB derived as: NB=λ×(effectb−
effecta)−(costb−costa). Where, λ is the willingness to pay 
for a unit improvement in effectiveness (ABC, QALYs and 
QoL) and subscripts ‘a’ and ‘b’ denote IST model a and 
IST model b, respectively. This approach allows costs and 
outcomes to be considered on the same monetary scale, 
taking account of sampling uncertainty and adjusting for 
baseline covariates and clustering.
Qualitative analysis plan
Interviews will be audio- recorded and transcribed verbatim 
by an external agency. Data will be analysed using thematic 
analysis33 conducted using NVivo software. A staged, 
collaborative and primarily inductive analytical approach 
will be adopted, allowing us to iteratively develop a set of 
themes to capture key concerns and topics, as well as more 
abstract or underlying issues. Although numbers in stake-
holder groups linked to each IST model may be relatively 
small, triangulation of the various stakeholder perspectives 
will allow us to obtain a broad picture of each IST model. 
Thus, we will be able to compare the IST models in terms 
of multiple stakeholders’ views, as well as analysing the 
data set as a whole to understand broadly common views 
and experiences of ISTs. Analysis will involve close collabo-
ration between study researchers, the qualitative lead and 
other key members of the study team. Service user and 
carer group meetings will be scheduled three times per 
year. The members of the advisory groups will receive easy 
read summary documents to be informed about the study 
progress, share views on different recruitment strategies, 
comment on the coding, analysis and interpretation of 
study findings.
Patient and public involvement
A service user reference group (Camden Disability 
Action) has supported the project and assisted with 
the research governance requirements including input 
to easy read versions of study materials (ie, informa-
tion sheets, consent forms) and piloting of instruments 
and qualitative interview topic guides with reference to 
people with ID. Family carer representatives from the 
Challenging Behaviour Foundation, an independent 
national charity of family carers of people with IDs and 
challenging behaviour, have also been involved in the 
conduct of the study and advising on recruitment as well 
as reviewing study- related information including the 
qualitative interviews topic guides. Meetings with both 
expert by experience groups are scheduled to take place 
every 3 months. Finally, there is service user and family 
caregiver representation at the study Steering Committee 
overseeing the study.
ETHICS
Ethical approval for this study was granted on 26 
June 2018 by the London Bromley Research Ethics 
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Committee (REC) (18/LO/0890). All personal data are 
handled in accordance with the Data Protection Act. All 
outcome measures are stored electronically, and access is 
restricted to the principal investigator of the study and 
nominated researchers. All identifiable documents are 
saved as password- protected files on password- protected 
computers. Confidential information (including signed 
consent forms) are stored separately from paper records 
(eg, Clinical Research Forms) in locked filing cabinets in 
a restricted area accessed by members of the University 
College London, Division of Psychiatry. Data manage-
ment and data quality checks will be performed by the 
research study team.
Dissemination plan
Our dissemination plan was developed in close collab-
oration with PPI representatives. Our dissemination 
and impact activities will include open- access academic 
publications in high- impact journals, presentations at 
academic and non- academic conferences, hosting a free 
public webinar about the study and producing briefings 
for carer groups, charities and NHS services. A news-
letter about the study progress will be sent to participants 
every 6 months and also available on the study website 
(https://www. ucl. ac. uk/ psychiatry/ research/ epidemi-
ology/ pis/ hassiotis- research- portfolio/ intensive- support- 
teams). The research team will submit manuscripts to 
peer- reviewed publications, and authorship inclusion and 
order will be guided by levels of contribution. All publica-
tion material will acknowledge the funding contribution 
from the National Institute for Health Research. Requests 
for access to the anonymised data and statistical code 
should be addressed to the corresponding author once 
the study funder report and main papers are published.
Study progress and COVID-19 impact
The first phase of the study has been completed and 
reported.20 The study has faced recruitment challenges 
which in the main included: reduced capacity to identify 
sufficient numbers of eligible participants due to small 
and static caseloads, services withdrawing or changing 
their remit halfway through the study, inadequate commu-
nication between ISTs and Clinical Research Networks 
which hampered research support. The number of ISTs 
was expanded to 23, 21 of which contributed partici-
pants to the study. The originally estimated 9 months of 
recruitment were extended to 17 with the last participant 
enrolled in May 2020; 180 9- month follow- ups have been 
completed. The last 4 months of recruitment occurred 
during the coronavirus pandemic and the subsequent 
lockdown which necessitated changes in study procedures 
including the introduction of remote completion of the 
research assessments and qualitative interviews. Those 
changes were non- substantial amendments (number 7) 
to the REC that had originally approved the study. Thir-
teen participants have been lost to follow- up with one 
death from COVID-19.
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